| Nanotherapy for Cancer: Targeting and Multi-functionality in the Future of Cancer Therapies. A Ediriwickrema, WM Saltzman ACS Biomaterials Science & Engineering 1 (2), 2015 | 210 | 2015 |
| A sunblock based on bioadhesive nanoparticles Y Deng, A Ediriwickrema, F Yang, J Lewis, M Girardi, WM Saltzman Nature materials 14 (12), 1278-1285, 2015 | 178 | 2015 |
| Single-cell mutational profiling enhances the clinical evaluation of AML MRD A Ediriwickrema, A Aleshin, JG Reiter, MR Corces, T Köhnke, M Stafford, ... Blood advances 4 (5), 943-952, 2020 | 76 | 2020 |
| Multi-layered nanoparticles for combination gene and drug delivery to tumors A Ediriwickrema, J Zhou, Y Deng, WM Saltzman Biomaterials 35 (34), 9343-9354, 2014 | 65 | 2014 |
| Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review Y Migdady, A Ediriwickrema, RP Jackson, W Kadi, R Gupta, F Socola, ... Blood Advances 4 (5), 815, 2020 | 30 | 2020 |
| Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience A Azizi, A Ediriwickrema, R Dutta, SA Patel, W Shomali, B Medeiros, ... Leukemia & Lymphoma 61 (11), 2700-2707, 2020 | 25 | 2020 |
| The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia Y Nakauchi, A Azizi, D Thomas, MR Corces, A Reinisch, R Sharma, ... Blood cancer discovery 3 (4), 346-367, 2022 | 21 | 2022 |
| Flow diverters and a tale of two aneurysms GA Kuzmik, T Williamson, A Ediriwickrema, A Andeejani, KR Bulsara Journal of NeuroInterventional Surgery 5 (4), e23-e23, 2013 | 18 | 2013 |
| Single-cell genomics in AML: extending the frontiers of AML research A Ediriwickrema, AJ Gentles, R Majeti Blood 141 (4), 345-355, 2023 | 17 | 2023 |
| Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia SA Patel, MR Lloyd, J Cerny, Q Shi, K Simin, A Ediriwickrema, ... Leukemia & Lymphoma 62 (14), 3348-3360, 2021 | 17 | 2021 |
| Intracranial stenting as monotherapy in subarachnoid hemorrhage and sickle cell disease A Ediriwickrema, T Williamson, R Hebert, C Matouk, MH Johnson, ... Journal of NeuroInterventional Surgery 5 (2), e4-e4, 2013 | 14 | 2013 |
| Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions SA Patel, J Cerny, WK Gerber, M Ramanathan, A Ediriwickrema, ... EJHaem 4 (4), 1059-1070, 2023 | 6 | 2023 |
| Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma A Espín-Pérez, K Brennan, AS Ediriwickrema, O Gevaert, IS Lossos, ... NPJ precision oncology 6 (1), 53, 2022 | 5 | 2022 |
| A case report of refractory immune thrombocytopenia (ITP) following reduced intensity conditioning (RIC) hematopoietic cell transplantation (HCT) for myelodysplastic syndrome … Y Migdady, R Gupta, A Ediriwickrema, F Socola, S Arai, BA Martin Blood 132, 4976, 2018 | 4 | 2018 |
| Tissue plasminogen activator via cross-collateralization for tandem internal carotid and middle cerebral artery occlusion KR Bulsara, A Ediriwickrema, J Pepper, F Robertson, J Aruny, J Schindler World Journal of Clinical Cases: WJCC 1 (9), 290, 2013 | 4 | 2013 |
| Topical formulation of hyperbranched polymer-coated particles Y Deng, A Ediriwickrema, WM Saltzman, M Girardi US Patent 11,918,695, 2024 | 3 | 2024 |
| Hyperbranched polyglycerol-coated particles and methods of making and using thereof Y Deng, A Ediriwickrema, WM Saltzman US Patent 10,238,581, 2019 | 2 | 2019 |
| Crescentic Glomerulonephritis With Immunoglobulin G4–Related Disease I Raber, A Ediriwickrema, J Higgins, N Kambham, AC Pao The American Journal of the Medical Sciences 354 (3), 236-239, 2017 | 2 | 2017 |
| Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity M Schwede, K Jahn, J Kuipers, LA Miles, RL Bowman, T Robinson, ... Leukemia, 1-10, 2024 | 1 | 2024 |
| Chromatin Accessibility Analysis Reveals Epigenetic Evolution Is a Common Mechanism of Relapse in Acute Myeloid Leukemia KA Nuno, A Azizi, T Koehnke, A Ediriwickrema, MR Corces, R Majeti Blood 138, 677, 2021 | 1 | 2021 |
W. Mark SaltzmanProfessor of Biomedical Engineering, Yale UniversityDirección de correo verificada de yale.edu
